32 research outputs found
“I attend at Vanguard and I attend here as well”: barriers to accessing healthcare services among older South Africans with HIV and non-communicable diseases
Background: HIV and non-communicable disease (NCD) are syndemic within sub-Saharan Africa especially among
older persons. The two epidemics interact with one another within a context of poverty, inequality and inequitable
access to healthcare resulting in an increase in those aged 50 and older living with HIV and experiencing an NCD comorbidity.
We explore the challenges of navigating healthcare for older persons living with HIV and NCD co-morbidity.
Methods: In-depth semi-structured interviews were conducted with a small sample of older persons living with HIV
(OPLWH). The perspectives of key informants were also sought to triangulate the evidence of OPLWH. The research
took place in two communities on the outskirts of Cape Town, South Africa. All interviews were conducted by a
trained interviewer and transcribed and translated for analysis. Thematic content analysis guided data analysis.
Results: OPLWH experienced an HIV-NCD syndemic. Our respondents sought care and accessed treatment for both
HIV and other chronic (and acute) conditions, though these services were provided at different health facilities or by
different health providers. Through the syndemic theory, it is possible to observe that OPLWH and NCDs face a
number of physical and structural barriers to accessing the healthcare system. These barriers are compounded by
separate appointments and spaces for each condition. These difficulties can exacerbate the impact of their ill-health
and perpetuate structural vulnerabilities. Despite policy changes towards integrated care, this is not the experience of
OPLWH in these communities.
Conclusions: The population living with HIV is aging increasing the likelihood that those living with HIV will also be
living with other chronic conditions including NCDs. Thus, it is essential that health policy address this basic need to
integrate HIV and NCD care
Effective Downregulation of HLA-A*2 and HLA-B*57 by Primary Human Immunodeficiency Virus Type 1 Isolates Cultured from Elite Suppressors▿
Elite controllers or suppressors (ES) are human immunodeficiency virus type 1 (HIV-1)-infected patients who control viral replication to <50 copies/ml without antiretroviral therapy. Downregulation of HLA class I molecules is an important mechanism used by HIV-1 to evade the immune system. In this study, we showed that primary isolates from ES are as effective as isolates obtained from patients with progressive HIV-1 disease at downregulating HLA-A*2 and HLA-B*57 molecules on primary CD4+ T cells. Thus, a diminished ability of viral isolates from ES to evade HIV-specific immune responses probably does not contribute to the control of viral replication in these patients
Recommended from our members
Statin Effects to Reduce Hepatosteatosis as Measured by Computed Tomography in Patients With Human Immunodeficiency Virus
Hepatosteatosis is highly prevalent among patients living with human immunodeficiency virus. In a 1-year, randomized, double-blind trial of atorvastatin or placebo, atorvastatin increased liver/spleen ratio among patients with nonalcoholic fatty liver disease, indicating a reduction in hepatosteatosis. This reduction in hepatosteatosis is associated with reduction in low-density lipoprotein cholesterol with statin therapy